4.8 Article Retracted Publication

被撤回的出版物: Vulnerability of Glioblastoma Cells to Catastrophic Vacuolization and Death Induced by a Small Molecule (Retracted article. See vol. 170, pg. 407, 2017)

期刊

CELL
卷 157, 期 2, 页码 -

出版社

CELL PRESS
DOI: 10.1016/j.cell.2014.02.021

关键词

-

资金

  1. Swedish Research Council for Medicine and Health
  2. Swedish Cancer Society
  3. Swedish strategic funds (DBRM, StratNeuro)
  4. Swedish Brain Foundation
  5. Hallsten Foundation
  6. Torsten Soderberg Professorship
  7. Wallenberg Foundation (Wallenberg Scholar grant)
  8. ERC advanced grant [232675]
  9. Chemical Biology Consortium Sweden (CBCS)
  10. Swedish Research Council
  11. European Research Council (ERC) [232675] Funding Source: European Research Council (ERC)

向作者/读者索取更多资源

Glioblastoma multiforme (GBM) is the most aggressive form of brain cancer with marginal life expectancy. Based on the assumption that GBM cells gain functions not necessarily involved in the cancerous process, patient-derived glioblastoma cells (GCs) were screened to identify cellular processes amenable for development of targeted treatments. The quinine-derivative NSC13316 reliably and selectively compromised viability. Synthetic chemical expansion reveals delicate structure-activity relationship and analogs with increased potency, termed Vacquinols. Vacquinols stimulate death by membrane ruffling, cell rounding, massive macropinocytic vacuole accumulation, ATP depletion, and cytoplasmic membrane rupture of GCs. The MAP kinase MKK4, identified by a shRNA screen, represents a critical signaling node. Vacquinol-1 displays excellent in vivo pharmacokinetics and brain exposure, attenuates disease progression, and prolongs survival in a GBM animal model. These results identify a vulnerability to massive vacuolization that can be targeted by small molecules and point to the possible exploitation of this process in the design of anticancer therapies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据